Larson Financial Group’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1K Buy
875
+79
+10% +$1.82K ﹤0.01% 2327
2026
Q2
$17.7K Hold
796
– – ﹤0.01% 2074
2026
Q1
$14.4K Buy
796
+774
+3,518% +$13.3K ﹤0.01% 2027
2025
Q4
$430 Buy
22
+3
+16% +$57 ﹤0.01% 3152
2025
Q3
$240 Buy
+19
New +$217 ﹤0.01% 3235
2025
Q2
– Sell
-46
Closed -$481 – 3341
2025
Q1
$481 Buy
+46
New +$658 ﹤0.01% 2588

Other funds holding DYN

Larson Financial Group's DYN Position: Q3 2026 in Review

Larson Financial Group increased its Dyne Therapeutics (DYN) stake by 9.9% in Q3 2026, buying an estimated $1.82K and bringing the position to 875 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.

Larson Financial Group first reported a position in DYN in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.7K in Q2 2026. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Larson Financial Group held 875 shares of Dyne Therapeutics worth $14.1K as of Q3 2026.
  • Larson Financial Group bought 79 Dyne Therapeutics shares in Q3 2026, an estimated $1.82K.
  • Dyne Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2327 holding.
  • Larson Financial Group first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Dyne Therapeutics position peaked at $17.7K in Q2 2026.
  • 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.